Presentation is loading. Please wait.

Presentation is loading. Please wait.

Figure 2 Biologics that target CD4+ T helper (TH)-cell subsets

Published byFrancine Jolicoeur Modified over 5 years ago

Similar presentations

Presentation on theme: "Figure 2 Biologics that target CD4+ T helper (TH)-cell subsets"— Presentation transcript:

1 Figure 2 Biologics that target CD4+ T helper (TH)-cell subsets
Figure 2 | Biologics that target CD4+ T helper (TH)-cell subsets. TH-cell subsets differentiate from activated CD4+ T cells (TH0) via a signalling pathway that is determined by cytokines produced from surrounding leukocytes (such as IL-12, IL-23, and IL-4). Differentiation of TH1-cell subsets can be inhibited by neutralizing IFNγ with AMG 811 or inhibiting the IL-12/IL-23 p40 subunit with ustekinumab. Ustekinumab, sirukumab, and tocilizumab also inhibit differentiation of TH17 cells. Terminally differentiated TH-cell subsets (TH1, TH17, and TH2 cells) synthesize distinct effector cytokines, many of which can be neutralized by biologics (highlighted in purple). Holdsworth, S. R. et al. (2016) Biologics for the treatment of autoimmune renal diseases Nat. Rev. Nephrol. doi: /nrneph

Download ppt "Figure 2 Biologics that target CD4+ T helper (TH)-cell subsets"

Similar presentations

Figure 1 Immune status and cytokine receptor common

Figure 1 Immune status and cytokine receptor common
Figure 1 CTLA-4 and PD-1–PD-L1 immune checkpoints

Figure 1 CTLA-4 and PD-1–PD-L1 immune checkpoints
Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph
Figure 5 A layered approach to the follow-up of patients with acute kidney disease (AKD) Figure 5 | A layered approach to the follow-up of patients with.

Figure 5 A layered approach to the follow-up of patients with acute kidney disease (AKD) Figure 5 | A layered approach to the follow-up of patients with.
Figure 2 Cell-mediated disease mechanisms of lupus nephritis

Figure 2 Cell-mediated disease mechanisms of lupus nephritis
Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph
Figure 6 Effects of adiponectin on podocyte function

Figure 6 Effects of adiponectin on podocyte function
Figure 4 Expression of coagulation protease receptors in renal cells

Figure 4 Expression of coagulation protease receptors in renal cells
The CD70-CD27 Axis, a New Brake in the T Helper 17 Cell Response

The CD70-CD27 Axis, a New Brake in the T Helper 17 Cell Response
Figure 4 Interactions between adipose, the microbiome and kidney

Figure 4 Interactions between adipose, the microbiome and kidney
Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph
Figure 1 Mechanisms of kidney injury in the setting of obesity

Figure 1 Mechanisms of kidney injury in the setting of obesity
Figure 2 Proinflammatory mechanisms in CKD

Figure 2 Proinflammatory mechanisms in CKD
Figure 1 Role of the kidney in glucose homeostasis

Figure 1 Role of the kidney in glucose homeostasis
Figure 1 Model of mechanosensation through primary cilia

Figure 1 Model of mechanosensation through primary cilia
Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph
Nat. Rev. Nephrol. doi: /nrneph

Nat. Rev. Nephrol. doi: /nrneph
Figure 6 The bioavailability of phosphate differs according to the protein source Figure 6 | The bioavailability of phosphate differs according to the.

Figure 6 The bioavailability of phosphate differs according to the protein source Figure 6 | The bioavailability of phosphate differs according to the.
Figure 7 The efficacy of phosphate-binder therapy

Figure 7 The efficacy of phosphate-binder therapy
Figure 3 The T-cell cytokine tree in IBD

Figure 3 The T-cell cytokine tree in IBD

Similar presentations

Ads by Google